A recent retrospective analysis found that among 25 patients with liver PEComa, 88% also had renal AML, and TSC2 patients had a higher prevalence of liver PEComa than TSC1 patients (18% vs 5%; P = 0.037) (22, 23). Here, TSC2 is linked to hepatic angiomyolipoma.